Form 4 for TDOC Teladoc Health, Inc.
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001477449-23-000101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-05 | 2023-12-04 | TDOC | GOREVIC JASON N | CEO, Dir | S - Sale+OE | $18.90 | -2,877 | 601.7K | -0.5% | -$54.4K |
| D | 2023-12-05 | 2023-12-01 | TDOC | GOREVIC JASON N | CEO, Dir | M - OptEx | — | +5,615 | 604.6K | +0.9% | — |
| D | 2023-12-05 | 2023-12-01 | TDOC | GOREVIC JASON N | CEO, Dir | M - OptEx | $0.00 | -5,615 | 28.1K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-04 | S | D | 2,877 | $18.90 | 601,734 | D | — | — | (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 2 | Common | Common Stock | 2023-12-01 | M | A | 5,615 | — | 604,611 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2023-12-01 | M | D | 5,615 | $0.00 | 28,075 | D | — · — to — | 5,615 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |